The trademark application ZEPOSIA was filed by Receptos LLC, a Limited Liability Company (the "Applicant"). The application was published for oppositions on April 7, 2022, and it was registered by office on July 15, 2022 without any oppositions.
The application was filed in English (French was selected as the second language).
Change of name and professional address of the trademark registration was recorded on January 11, 2024.
Goods And Services
The mark was filed in class 5 with following description of goods:
Pharmaceutical preparations for use in the treatment of leukemia, auto inflammatory disease, autoimmune disease, blood disease, cancer, multiple sclerosis, ulcerative colitis, arthritis, musculoskeletal and skin diseases